The global diabetes market is experiencing exponential expansion driven by the increasing prevalence of this chronic disease. At the forefront of this evolution are leading developers of GLP-1 receptor agonists, a https://fatallisto.com/story10346293/leading-glp-1-manufacturers-innovation-in-diabetes-treatment